2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35205643 | Precision Medicine for BRCA/PALB2-Mutated Pancreatic Cancer and Emerging Strategies to Improve Therapeutic Responses to PARP Inhibition. | 2022 Feb 11 | 1 |
2 | 29223478 | Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. | 2018 Jan | 1 |